A Form 4 filed with the SEC on September 16, 2026, discloses that Christian O. Henry, a director of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), sold 5,000 shares of Class A Common Stock on September 15, 2026.
Key Highlights
- Reporting Person: Christian O. Henry, identified as a Director of Ginkgo Bioworks Holdings, Inc.
- Transaction: 5,000 shares of Class A Common Stock disposed of (transaction code S) on September 15, 2026.
- Weighted Average Price: $7.081 per share, with individual transaction prices ranging from $7.074 to $7.085, inclusive.
- Remaining Ownership: 19,310 shares of Class A Common Stock held directly following the reported transaction.
- No Derivative Activity: No derivative securities were acquired or disposed of in connection with this filing.
Director Henry's Class A Share Sale at Ginkgo Bioworks
According to the Form 4 filing, Christian O. Henry, a director at Ginkgo Bioworks Holdings, Inc., sold 5,000 shares of the company's Class A Common Stock on September 15, 2026. The filing was signed by Karen Tepichin as Attorney-in-Fact and submitted to the SEC on September 16, 2026. The shares were sold directly, with ownership listed as direct (D) both before and after the transaction.
The filing discloses that the price of $7.081 reported is a weighted average. The shares were sold across multiple transactions at prices ranging from $7.074 to $7.085, inclusive. According to the filing, Henry "undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."
Following the reported sale, Henry beneficially owns 19,310 shares of Class A Common Stock directly. The filing contains no entries in Table II, indicating no derivative securities were involved in this disclosure. The filing does not indicate whether the transaction was made pursuant to a Rule 10b5-1 plan, as that box was not checked.
What Was Disclosed
The filing reports a sale of 5,000 shares of Ginkgo Bioworks Class A Common Stock by director Christian O. Henry at a weighted average price of $7.081 on September 15, 2026, leaving him with 19,310 shares held directly.




Please wait processing your request...